Matthew Seibt - Jan 14, 2022 Form 4 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Chief Commercial Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Stock symbol
ACER
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 03:32 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACER Employee Stock Option (right to buy) Award $0 +25K $0.00 25K Jan 14, 2022 Common Stock 25K $2.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on January 14, 2023, and the remaining 75% of the shares vest quarterly over the remaining three years.